Jim Greenwood

Touring CA Biotech Companies with Governor Howard Dean, MD

Posted by Jim Greenwood on January 8, 2010 at 11:27am EST

Last summer, BIO joined with former Vermont Governor Howard Dean to advocate for biosimilar legislation that protects patient safety and promotes necessary incentives for continued innovation of biologics.

Meeting India's Biotech Community

Posted by Jim Greenwood on November 12, 2009 at 7:59am EST

Biotechnology is a global enterprise.  The United States continues to play the dominant role but European and Asian nations are continually expanding their capabilities. 

In preparation for BIO’s first ever partnering meeting in India in September 2010, I am travelling the subcontinent to promote the event and to assess the country's biotech capabilities and needs.

On November 4th in Mumbai, I visited Reliance Life Sciences which represents a huge investment in biotech from one of India’s largest and most well known companies.  Whil

Encouraging Louisiana to Partner with BIO

Posted by Jim Greenwood on October 26, 2009 at 8:31am EDT

Louisiana is one of just a few states that do not yet have a BIO affiliate. I was invited to speak to community leaders in New Orleans by Jim McNamara, a local real estate investor who is presently the Secretary of the Board of the New Orleans BioInnovation Center, a Member of the Greater New Orleans Biosciences Economic Development District and a Commissioner of the Downtown Development District of New Orleans.

Jim believes biotechnology can be key to the Big Easy’s recovery from the ravages of Hurricane Katrina.

The Burrill Report: Interview with Jim Greenwood

Posted by Jim Greenwood on October 23, 2009 at 11:25am EDT

The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about the upcoming Eighth Annual BIO Investor Forum’s opening plenary session on healthcare reform. Greenwood will be moderating the session, “Healthcare Reform: Sustaining Biotech Innovation in a New World.”


Listen to the podcast

BIO President & CEO Jim Greenwood On How Global Financial Crisis Affects Biotech Innovation

Posted by danmcgirt on October 17, 2008 at 3:02pm EDT

How is the global financial crisis and credit crunch affecting the ability of biotech companies to continue their research and development of innovative new products? BIO President & CEO Jim Greenwood discusses the impact of the financial meltdown on biotech companies.

Day 3 observations

Posted by Darren Fast on June 20, 2008 at 11:50am EDT

Had another great day at BIO yesterday.  I was particularly impressed with the lunch session.  Jim Greenwood painted a compelling picture of the power of biotechnology.  Colin Powell was impressive as well.

Syndicate content